Ardsley Advisory Partners LP trimmed its holdings in SunOpta Inc. (NASDAQ:STKL - Free Report) TSE: SOY by 17.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,390,000 shares of the company's stock after selling 290,000 shares during the quarter. SunOpta comprises approximately 1.7% of Ardsley Advisory Partners LP's portfolio, making the stock its 13th biggest position. Ardsley Advisory Partners LP owned approximately 1.16% of SunOpta worth $10,703,000 as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. Barclays PLC increased its stake in SunOpta by 103.3% in the third quarter. Barclays PLC now owns 178,954 shares of the company's stock valued at $1,142,000 after purchasing an additional 90,937 shares during the period. JPMorgan Chase & Co. raised its holdings in SunOpta by 12.3% during the third quarter. JPMorgan Chase & Co. now owns 515,170 shares of the company's stock worth $3,287,000 after purchasing an additional 56,621 shares in the last quarter. Harbor Capital Advisors Inc. increased its position in SunOpta by 65.6% during the 4th quarter. Harbor Capital Advisors Inc. now owns 1,761,922 shares of the company's stock worth $13,567,000 after purchasing an additional 698,004 shares during the period. Ballentine Partners LLC raised its stake in shares of SunOpta by 39.3% during the 4th quarter. Ballentine Partners LLC now owns 30,664 shares of the company's stock worth $236,000 after buying an additional 8,652 shares in the last quarter. Finally, SG Americas Securities LLC grew its holdings in SunOpta by 1.1% during the fourth quarter. SG Americas Securities LLC now owns 1,012,814 shares of the company's stock worth $7,799,000 after acquiring an additional 10,582 shares during the period. 85.39% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, StockNews.com raised SunOpta from a "sell" rating to a "hold" rating in a report on Tuesday, March 11th.
Get Our Latest Stock Analysis on SunOpta
Insider Transactions at SunOpta
In other SunOpta news, SVP Bryan P. Clark sold 8,500 shares of the firm's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $5.32, for a total transaction of $45,220.00. Following the completion of the transaction, the senior vice president now directly owns 28,150 shares in the company, valued at approximately $149,758. This trade represents a 23.19 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.90% of the company's stock.
SunOpta Price Performance
SunOpta stock traded up $0.03 during mid-day trading on Monday, reaching $4.55. The company had a trading volume of 1,169,223 shares, compared to its average volume of 752,499. The stock's 50-day simple moving average is $4.77 and its 200-day simple moving average is $6.45. SunOpta Inc. has a 1 year low of $3.65 and a 1 year high of $8.11. The company has a debt-to-equity ratio of 1.61, a current ratio of 1.20 and a quick ratio of 0.53. The company has a market capitalization of $544.89 million, a P/E ratio of -25.28 and a beta of 1.83.
SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.06 earnings per share for the quarter, meeting the consensus estimate of $0.06. The firm had revenue of $193.91 million during the quarter, compared to the consensus estimate of $189.90 million. SunOpta had a positive return on equity of 7.92% and a negative net margin of 2.74%. On average, equities analysts predict that SunOpta Inc. will post 0.13 EPS for the current year.
SunOpta Profile
(
Free Report)
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Featured Stories

Before you consider SunOpta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.
While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.